Going to a neuroendocrine cancer patient conference saved my life.
Long Island, NY, Indianapolis, IN, Dallas, TX (PRWEB) July 12, 2011
The president of a non-profit group that promotes awareness of neuroendocrine cancer has announced the Carcinoid Cancer Awareness Network’s 2011 Patient Conference schedule:
-2011 Long Island Neuroendocrine Cancer Patient Conference, Holiday Inn, Carle Place on August 20th.
-NET Cancer Patient Conference Indianapolis, Hyatt Regency at the State Capitol on September 17th.
-NET Cancer Patient Conference Dallas, TX, DoubleTree Hotel Dallas near the Galleria on Oct 15th.
According to Bob Wahmann of CCAN, “the faculty and the topics being covered at these events are absolutely astounding. These conferences need to be affordable so we only charge a small commitment fee to attendees. I wish we could promote them more extensively. If you are a medical care provider or a patient with a neuroendocrine cancer, you will hear things at this conference that can really change lives.” Each full day event includes presentations by 5 neuroendocrine cancer experts, an expert question & answer panel, lunch, snacks and networking.
Here is a perfect opportunity to learn from some of the foremost experts in the world: Dr. Thomas O’Dorisio, Dr. Ebrahim Delpassand, Dr. Eugene Woltering, Dr. Lowell Anthony, Dr. Phil Boudreaux, Dr. Aaron Vinik, Dr. Hal Gerstein, Dr. Steven Libutti, Dr. Patrick C. Molloy- all members of the North American Neuroendocrine Tumor Society (NANETS.) They will cover topics such as:
‘Prioritizing Treatment Options for NET Cancer Patients’ -- ‘The Role of Surgery In NET Cancer?’ -- ‘Neuroendocrine Tumors: Recognition, Potential New Therapies & a Look at the Future’ -- ‘Choosing Options of Care & the Value of Tumor Markers in the Process’ -- ‘What’s New in PRRT Treatments for NETs?’ -- ‘Evaluation and Treatment Of Pancreatic NETS’
Who Should Attend a Conference?
Doctors, nurses, physician’s assistants, students, techs, patients, caregivers- anyone who might be in a position to suspect, diagnose, treat and help carcinoid / NET cancer patients. Medical professionals will also have the opportunity to join the North American NeuroEndocrine Tumor Society (NANETS.) The purpose of this professional organization is to improve NET disease management through increased research and educational opportunities. Think NET cancer is rare? There are over 120,000 patients in the US that don’t agree, and 12,000 new ones diagnosed every year.
Patients need to be involved so that they are aware of the treatment options available to them. Nationally known Carcinoid/NET expert Dr. Eugene Woltering explains that “educating neuroendocrine cancer patients is one of the best methods of getting current information into the hands of the medical community.” This concept works. Recently a new patient was diagnosed by a dermatologist because of information given to the physician by a carcinoid cancer survivor.
Maryann Wahmann, VP of CCAN and herself a carcinoid cancer survivor tells us that, “These events definitely save lives! My husband and I went to our first patient conference in 2003 and were absolutely shocked by the information we got there that we didn’t get from our local doctors. Going there saved my life. Because NET cancer has no celebrity spokesperson and little publicity, our researchers get modest funding. Many carcinoid cancer patients go untreated for years or are told they have other problems.”
Call CCAN’s office at 516-781-7814 or visit http://www.carcinoidawareness.org for more information.